Bergen, 10 April 2006: With reference to the Company`s notification on 31 March 2006 regarding the ordinary general assembly taking place 20 April 2006, it is proposed that:

Chairman of the Board Mårten Wigstøl and board members Hans Hekland and Gisela Sitbon are re- elected.

Dr. Jochen Felbel seeks not to be re-elected in the Board of Directors in order to take a consultant position as Medical Director to the Company. Dr Jochen Felbel is currently Medical Director of Abbott Diabetes Care Europe, Middle East, Africa and India, and has experience in developing trial protocols and from commercial business development and licensing. Dr. Felbel`s academic achievements include an MD, two Ph.D.`s and an MBA in the Medical and Business fields. Dr. Felbel is a German citizen and resides in Wiesbaden, Germany. Dr. Felbel will replace Dr Dagfinn Øgreid, who will retain a position as Clinical Advisor to the Company.

Ove Lind seeks not to be re-elected in the Board of Directors due to personal circumstances.

In addition, it is proposed that the following persons are elected as new board members: Robert Allnutt
Prof. Dr. Med. Annika Lindblom
PD Dr. med. Dipl. chem. Elke Holinski-Feder

Robert Allnutt is the former Group Legal Adviser and Company Secretary of Amersham plc, a world leader in medical diagnostics and life sciences, now part of GE Healthcare. In addition to responsibility for legal services and its organisational development, Mr Allnutt was a member of the Amersham Executive Committee involved in development of strategy, mergers, acquisitions and disposals, and of the Intellectual Property Strategy Committee. Prior to his time at Amersham, his work as a legal adviser spanned a broad spectrum of industries and commercial clients. Mr Allnutt is a UK citizen and lives near London.

Prof. Dr. Med. Annika Lindblom is Professor in Cancer Genetics at Sweden`s Karolinska Institute. Prof. Lindblom held various other high level academic and clinical positions, including as Professor in Medical genetics at Linköpings University and as Senior Doctor at Karolinska Hospital. Prof. Lindblom is a member of the editorial board for Critical Reviews in Oncogenesis and reviewer in over 15 top scientific journals covering cancer genetics. In 1990, she started a practice for genetic counselling for families with hereditary cancer. Prof. Lindblom is a Swedish citizen located in Stockholm.

PD Dr. med. Dipl. chem. Elke Holinski-Feder is Managing Director of the Medical Genetics Center, an accredited laboratory based in Munich, Germany. The Medical Genetics Center processes over 6000 molecular genetic tests annually for a large variety of diseases. Prof. Holinski-Feder is affiliated as an Adjunct Professor in Human Genetics with the Department of Medical Genetics at the University of Munich. She has substantial experience as a specialist in both genetics research and genetic testing. Prof. Holinski-Feder is a German Citizen and lives in Munich.

Bergen, 10 April 2006
The Board of Directors for NorDiag ASA